INGN — Inogen Inc
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1294133 ·
Last close
$6.54
Market Cap
$177.07M
52W High
$7.67
52W Low
$5.88
ADV30
300,487
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 85,109,000 | 37,863,000 | -9,336,000 | -8,324,000 | 285,926,000 | 93,112,000 | 103,020,000 |
| Dec 2025 | 81,721,000 | 35,236,000 | -9,306,000 | -7,127,000 | 298,625,000 | 103,729,000 | 106,394,000 |
| Sep 2025 | 92,390,000 | 41,316,000 | -7,116,000 | -5,294,000 | 307,009,000 | 106,476,000 | 109,834,000 |
| Jun 2025 | 92,277,000 | 41,341,000 | -6,129,000 | -4,152,000 | 312,040,000 | 103,685,000 | 112,549,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-11,216,000
Investing CF
$-26,209,000
Financing CF
$24,182,000
CapEx
$-10,383,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.86
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-175,584,000
Inventory
$25,969,000
Receivables
$38,863,000
ST Investments
$15,848,000
EBIT TTM
$-30,207,000
Pretax Income TTM
$-23,379,000
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$351,496,992
EBITDA
$-8,812,000
Free Cash Flow
$-2,406,250
Enterprise Value
$83,560,592
Total Cash
$110,171,000
Total Debt
$16,935,000
Shares Out
27,074,516
Trailing EPS
$-0.91
Book Value
$6.68
ROE
-13.1%
ROA
-6.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 348,668,000 | -30,207,000 | -22,747,000 | 298,625,000 | 106,394,000 | — | -11,216,000 |
| Dec 2024 | 335,705,000 | -42,516,000 | -35,888,000 | 296,185,000 | 122,325,000 | — | 5,914,000 |
| Dec 2023 | 315,660,000 | -76,492,000 | -102,449,000 | 326,194,000 | 121,382,000 | — | -3,234,000 |
| Dec 2022 | 377,241,000 | -33,082,000 | -83,772,000 | 405,041,000 | 107,635,000 | — | -37,532,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.26
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NYXH | Nyxoah SA | $171.12M | $1.71 | — |
| APYX | Apyx Medical Corp | $184.44M | $4.38 | — |
| STXS | Stereotaxis, Inc. | $166.15M | $1.70 | — |
| LUCD | Lucid Diagnostics Inc. | $190.77M | $1.00 | — |
| EMBC | Embecta Corp. | $192.22M | $3.24 | — |
News headlines (Yahoo Finance, 1h cache)
Inogen Announces the Appointment of Andy Reding as Chief Operating Officer
2026-07-01 20:05 · Yahoo
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
2026-06-25 14:12 · Yahoo
How The Inogen (INGN) Story Is Shifting With New Targets And Execution Questions
2026-05-11 00:18 · Yahoo
INGN Stock Dips on Q1 Earnings Miss, Sales Up Y/Y, Gross Margin Improves
2026-05-08 14:41 · Yahoo
Inogen, Inc. Q1 2026 Earnings Call Summary
2026-05-08 12:30 · Yahoo
Inogen Q1 Earnings Call Highlights
2026-05-08 04:06 · Yahoo
Inogen (INGN) Reports Q1 Loss, Beats Revenue Estimates
2026-05-07 23:05 · Yahoo
Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates
2026-05-05 13:15 · Yahoo
We're Not Very Worried About Inogen's (NASDAQ:INGN) Cash Burn Rate
2026-04-28 10:28 · Yahoo
Beta Bionics, Inc. (BBNX) Reports Q1 Loss, Misses Revenue Estimates
2026-04-21 21:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.